nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP2C9—brain cancer	0.471	1	CbGaD
Haloperidol—CYP2D6—Lomustine—brain cancer	0.0441	0.191	CbGbCtD
Haloperidol—CYP1A2—Carmustine—brain cancer	0.0437	0.189	CbGbCtD
Haloperidol—CYP2D6—Hydroxyurea—brain cancer	0.0334	0.145	CbGbCtD
Haloperidol—CYP3A4—Temozolomide—brain cancer	0.033	0.143	CbGbCtD
Haloperidol—CYP3A4—Lomustine—brain cancer	0.0281	0.122	CbGbCtD
Haloperidol—CYP3A5—Etoposide—brain cancer	0.0174	0.0754	CbGbCtD
Haloperidol—CYP1A2—Etoposide—brain cancer	0.0129	0.0561	CbGbCtD
Haloperidol—ABCB1—Etoposide—brain cancer	0.0113	0.0491	CbGbCtD
Haloperidol—HTR1D—meninx—brain cancer	0.00861	0.0686	CbGeAlD
Haloperidol—HTR1B—dura mater—brain cancer	0.00819	0.0652	CbGeAlD
Haloperidol—HTR1D—dura mater—brain cancer	0.00793	0.0632	CbGeAlD
Haloperidol—CYP3A4—Etoposide—brain cancer	0.00678	0.0294	CbGbCtD
Haloperidol—GRIN2B—telencephalic ventricle—brain cancer	0.00419	0.0334	CbGeAlD
Haloperidol—HTR1B—trigeminal nerve—brain cancer	0.00352	0.0281	CbGeAlD
Haloperidol—DRD3—telencephalic ventricle—brain cancer	0.00351	0.028	CbGeAlD
Haloperidol—HTR1D—trigeminal nerve—brain cancer	0.00341	0.0272	CbGeAlD
Haloperidol—HTR2A—choroid plexus—brain cancer	0.00335	0.0267	CbGeAlD
Haloperidol—GRIN2B—ganglion—brain cancer	0.00261	0.0208	CbGeAlD
Haloperidol—HRH1—nose—brain cancer	0.00258	0.0206	CbGeAlD
Haloperidol—DRD1—telencephalic ventricle—brain cancer	0.00252	0.0201	CbGeAlD
Haloperidol—HTR1B—cranial nerve—brain cancer	0.00251	0.02	CbGeAlD
Haloperidol—HTR1D—cranial nerve—brain cancer	0.00243	0.0194	CbGeAlD
Haloperidol—HTR1B—telencephalic ventricle—brain cancer	0.00204	0.0163	CbGeAlD
Haloperidol—GRIN2B—hindbrain—brain cancer	0.00198	0.0158	CbGeAlD
Haloperidol—HTR1D—telencephalic ventricle—brain cancer	0.00197	0.0157	CbGeAlD
Haloperidol—HTR2A—trigeminal nerve—brain cancer	0.00169	0.0135	CbGeAlD
Haloperidol—HTR2A—cerebellar cortex—brain cancer	0.00169	0.0134	CbGeAlD
Haloperidol—DRD1—ganglion—brain cancer	0.00157	0.0125	CbGeAlD
Haloperidol—HTR2A—vein—brain cancer	0.00153	0.0122	CbGeAlD
Haloperidol—DRD2—telencephalic ventricle—brain cancer	0.00149	0.0119	CbGeAlD
Haloperidol—Moclobemide—CYP2C9—brain cancer	0.00132	1	CrCbGaD
Haloperidol—HTR1B—ganglion—brain cancer	0.00127	0.0101	CbGeAlD
Haloperidol—HTR1D—ganglion—brain cancer	0.00123	0.00979	CbGeAlD
Haloperidol—HTR2A—cranial nerve—brain cancer	0.00121	0.00961	CbGeAlD
Haloperidol—HTR2A—pons—brain cancer	0.00119	0.0095	CbGeAlD
Haloperidol—GRIN2B—brainstem—brain cancer	0.00113	0.00904	CbGeAlD
Haloperidol—EBP—endocrine gland—brain cancer	0.00103	0.00824	CbGeAlD
Haloperidol—HTR1B—blood vessel—brain cancer	0.00101	0.00804	CbGeAlD
Haloperidol—GRIN2B—telencephalon—brain cancer	0.00101	0.00803	CbGeAlD
Haloperidol—HTR2A—telencephalic ventricle—brain cancer	0.000981	0.00782	CbGeAlD
Haloperidol—HTR1D—blood vessel—brain cancer	0.000977	0.00779	CbGeAlD
Haloperidol—DRD2—ganglion—brain cancer	0.000926	0.00738	CbGeAlD
Haloperidol—HTR2A—pineal body—brain cancer	0.000851	0.00678	CbGeAlD
Haloperidol—Alopecia—Lomustine—brain cancer	0.000833	0.00762	CcSEcCtD
Haloperidol—Breast pain—Temozolomide—brain cancer	0.000826	0.00756	CcSEcCtD
Haloperidol—Amenorrhoea—Temozolomide—brain cancer	0.00082	0.00751	CcSEcCtD
Haloperidol—Leukocytosis—Carmustine—brain cancer	0.000793	0.00726	CcSEcCtD
Haloperidol—Laryngospasm—Etoposide—brain cancer	0.000772	0.00707	CcSEcCtD
Haloperidol—Gait disturbance—Carmustine—brain cancer	0.000764	0.00699	CcSEcCtD
Haloperidol—Dysphagia—Procarbazine—brain cancer	0.000748	0.00684	CcSEcCtD
Haloperidol—CBR1—telencephalon—brain cancer	0.000747	0.00595	CbGeAlD
Haloperidol—Injection site reaction—Carmustine—brain cancer	0.000741	0.00678	CcSEcCtD
Haloperidol—Gait disturbance—Temozolomide—brain cancer	0.000738	0.00676	CcSEcCtD
Haloperidol—Leukopenia—Lomustine—brain cancer	0.000734	0.00672	CcSEcCtD
Haloperidol—Sweating increased—Procarbazine—brain cancer	0.000728	0.00667	CcSEcCtD
Haloperidol—Pancytopenia—Procarbazine—brain cancer	0.00071	0.0065	CcSEcCtD
Haloperidol—GRIN2B—spinal cord—brain cancer	0.000706	0.00562	CbGeAlD
Haloperidol—DRD2—hindbrain—brain cancer	0.000702	0.00559	CbGeAlD
Haloperidol—Photosensitivity reaction—Procarbazine—brain cancer	0.000682	0.00625	CcSEcCtD
Haloperidol—DRD1—brainstem—brain cancer	0.000681	0.00543	CbGeAlD
Haloperidol—Gynaecomastia—Carmustine—brain cancer	0.000667	0.00611	CcSEcCtD
Haloperidol—Drowsiness—Procarbazine—brain cancer	0.000667	0.0061	CcSEcCtD
Haloperidol—Thrombocytopenia—Lomustine—brain cancer	0.000656	0.006	CcSEcCtD
Haloperidol—Jaundice—Procarbazine—brain cancer	0.00065	0.00595	CcSEcCtD
Haloperidol—Face oedema—Hydroxyurea—brain cancer	0.000646	0.00592	CcSEcCtD
Haloperidol—Anorexia—Lomustine—brain cancer	0.000638	0.00584	CcSEcCtD
Haloperidol—GRIN2B—endocrine gland—brain cancer	0.000635	0.00506	CbGeAlD
Haloperidol—GRIN2B—head—brain cancer	0.000627	0.005	CbGeAlD
Haloperidol—UGT1A9—endocrine gland—brain cancer	0.000626	0.00499	CbGeAlD
Haloperidol—CBR1—gonad—brain cancer	0.000623	0.00497	CbGeAlD
Haloperidol—H1F0—telencephalon—brain cancer	0.000612	0.00488	CbGeAlD
Haloperidol—HTR2A—ganglion—brain cancer	0.000611	0.00487	CbGeAlD
Haloperidol—CBR1—pituitary gland—brain cancer	0.000608	0.00485	CbGeAlD
Haloperidol—Body temperature increased—Carboplatin—brain cancer	0.000605	0.00554	CcSEcCtD
Haloperidol—Breast disorder—Hydroxyurea—brain cancer	0.000605	0.00554	CcSEcCtD
Haloperidol—DRD1—telencephalon—brain cancer	0.000604	0.00482	CbGeAlD
Haloperidol—Hallucination—Procarbazine—brain cancer	0.000595	0.00545	CcSEcCtD
Haloperidol—CBR1—medulla oblongata—brain cancer	0.000587	0.00468	CbGeAlD
Haloperidol—Decreased appetite—Lomustine—brain cancer	0.000582	0.00533	CcSEcCtD
Haloperidol—GRIN2B—central nervous system—brain cancer	0.000572	0.00456	CbGeAlD
Haloperidol—GRIN2B—cerebellum—brain cancer	0.00056	0.00446	CbGeAlD
Haloperidol—Dermatitis exfoliative—Temozolomide—brain cancer	0.000554	0.00507	CcSEcCtD
Haloperidol—HTR1B—brainstem—brain cancer	0.000552	0.0044	CbGeAlD
Haloperidol—Pancytopenia—Hydroxyurea—brain cancer	0.00055	0.00503	CcSEcCtD
Haloperidol—Hyponatraemia—Carmustine—brain cancer	0.000543	0.00497	CcSEcCtD
Haloperidol—DRD4—brain—brain cancer	0.000542	0.00432	CbGeAlD
Haloperidol—Neutropenia—Hydroxyurea—brain cancer	0.000541	0.00495	CcSEcCtD
Haloperidol—CBR1—midbrain—brain cancer	0.000536	0.00427	CbGeAlD
Haloperidol—HTR1D—brainstem—brain cancer	0.000534	0.00426	CbGeAlD
Haloperidol—Body temperature increased—Lomustine—brain cancer	0.000529	0.00485	CcSEcCtD
Haloperidol—Alopecia—Procarbazine—brain cancer	0.000529	0.00484	CcSEcCtD
Haloperidol—Weight increased—Hydroxyurea—brain cancer	0.000527	0.00482	CcSEcCtD
Haloperidol—HTR2A—endothelium—brain cancer	0.000526	0.0042	CbGeAlD
Haloperidol—DRD3—head—brain cancer	0.000526	0.00419	CbGeAlD
Haloperidol—CBR1—spinal cord—brain cancer	0.000523	0.00417	CbGeAlD
Haloperidol—Face oedema—Carmustine—brain cancer	0.000522	0.00478	CcSEcCtD
Haloperidol—CYP3A7—endocrine gland—brain cancer	0.000521	0.00415	CbGeAlD
Haloperidol—Drowsiness—Hydroxyurea—brain cancer	0.000516	0.00472	CcSEcCtD
Haloperidol—H1F0—gonad—brain cancer	0.000511	0.00407	CbGeAlD
Haloperidol—Face oedema—Temozolomide—brain cancer	0.000505	0.00462	CcSEcCtD
Haloperidol—Liver function test abnormal—Carmustine—brain cancer	0.0005	0.00457	CcSEcCtD
Haloperidol—H1F0—pituitary gland—brain cancer	0.000498	0.00397	CbGeAlD
Haloperidol—HTR1B—telencephalon—brain cancer	0.00049	0.0039	CbGeAlD
Haloperidol—Tremor—Procarbazine—brain cancer	0.000488	0.00447	CcSEcCtD
Haloperidol—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000488	0.00447	CcSEcCtD
Haloperidol—HTR2A—blood vessel—brain cancer	0.000485	0.00387	CbGeAlD
Haloperidol—Anaemia—Procarbazine—brain cancer	0.000482	0.00441	CcSEcCtD
Haloperidol—H1F0—medulla oblongata—brain cancer	0.000481	0.00383	CbGeAlD
Haloperidol—DRD3—central nervous system—brain cancer	0.00048	0.00382	CbGeAlD
Haloperidol—HTR1D—telencephalon—brain cancer	0.000474	0.00378	CbGeAlD
Haloperidol—Breast disorder—Temozolomide—brain cancer	0.000473	0.00433	CcSEcCtD
Haloperidol—CBR1—endocrine gland—brain cancer	0.000471	0.00375	CbGeAlD
Haloperidol—Dysphagia—Carmustine—brain cancer	0.000468	0.00428	CcSEcCtD
Haloperidol—Leukopenia—Procarbazine—brain cancer	0.000466	0.00427	CcSEcCtD
Haloperidol—CBR1—head—brain cancer	0.000465	0.00371	CbGeAlD
Haloperidol—HTR2A—hindbrain—brain cancer	0.000463	0.00369	CbGeAlD
Haloperidol—Hallucination—Hydroxyurea—brain cancer	0.000461	0.00422	CcSEcCtD
Haloperidol—GRIN2B—brain—brain cancer	0.000454	0.00362	CbGeAlD
Haloperidol—Dysphagia—Temozolomide—brain cancer	0.000452	0.00414	CcSEcCtD
Haloperidol—Convulsion—Procarbazine—brain cancer	0.000451	0.00413	CcSEcCtD
Haloperidol—Hypertension—Procarbazine—brain cancer	0.00045	0.00412	CcSEcCtD
Haloperidol—Pancytopenia—Carmustine—brain cancer	0.000444	0.00407	CcSEcCtD
Haloperidol—SIGMAR1—telencephalon—brain cancer	0.000442	0.00352	CbGeAlD
Haloperidol—Anxiety—Procarbazine—brain cancer	0.000442	0.00405	CcSEcCtD
Haloperidol—HTR2B—telencephalon—brain cancer	0.000441	0.00351	CbGeAlD
Haloperidol—Sweating increased—Temozolomide—brain cancer	0.00044	0.00403	CcSEcCtD
Haloperidol—H1F0—midbrain—brain cancer	0.00044	0.0035	CbGeAlD
Haloperidol—Neutropenia—Carmustine—brain cancer	0.000437	0.004	CcSEcCtD
Haloperidol—DRD1—midbrain—brain cancer	0.000434	0.00346	CbGeAlD
Haloperidol—Dry mouth—Procarbazine—brain cancer	0.000434	0.00397	CcSEcCtD
Haloperidol—Pancytopenia—Temozolomide—brain cancer	0.000429	0.00393	CcSEcCtD
Haloperidol—H1F0—spinal cord—brain cancer	0.000429	0.00342	CbGeAlD
Haloperidol—Confusional state—Procarbazine—brain cancer	0.000429	0.00392	CcSEcCtD
Haloperidol—Vomiting—Lomustine—brain cancer	0.000426	0.0039	CcSEcCtD
Haloperidol—Oedema—Procarbazine—brain cancer	0.000425	0.00389	CcSEcCtD
Haloperidol—CBR1—central nervous system—brain cancer	0.000425	0.00338	CbGeAlD
Haloperidol—Neutropenia—Temozolomide—brain cancer	0.000423	0.00387	CcSEcCtD
Haloperidol—Hyperglycaemia—Carmustine—brain cancer	0.000422	0.00386	CcSEcCtD
Haloperidol—CYP2D6—hindbrain—brain cancer	0.000422	0.00336	CbGeAlD
Haloperidol—Angiopathy—Hydroxyurea—brain cancer	0.00042	0.00385	CcSEcCtD
Haloperidol—Erectile dysfunction—Temozolomide—brain cancer	0.000416	0.00381	CcSEcCtD
Haloperidol—Thrombocytopenia—Procarbazine—brain cancer	0.000416	0.00381	CcSEcCtD
Haloperidol—Depression—Carmustine—brain cancer	0.000416	0.00381	CcSEcCtD
Haloperidol—CBR1—cerebellum—brain cancer	0.000415	0.00331	CbGeAlD
Haloperidol—Tachycardia—Procarbazine—brain cancer	0.000415	0.0038	CcSEcCtD
Haloperidol—Photosensitivity reaction—Temozolomide—brain cancer	0.000413	0.00378	CcSEcCtD
Haloperidol—Weight increased—Temozolomide—brain cancer	0.000411	0.00377	CcSEcCtD
Haloperidol—Hyperhidrosis—Procarbazine—brain cancer	0.000411	0.00376	CcSEcCtD
Haloperidol—Alopecia—Hydroxyurea—brain cancer	0.000409	0.00375	CcSEcCtD
Haloperidol—Weight decreased—Temozolomide—brain cancer	0.000409	0.00374	CcSEcCtD
Haloperidol—Hyperglycaemia—Temozolomide—brain cancer	0.000408	0.00373	CcSEcCtD
Haloperidol—Anorexia—Procarbazine—brain cancer	0.000405	0.00371	CcSEcCtD
Haloperidol—DRD2—brainstem—brain cancer	0.000402	0.00321	CbGeAlD
Haloperidol—Depression—Temozolomide—brain cancer	0.000402	0.00368	CcSEcCtD
Haloperidol—Cardiac arrest—Etoposide—brain cancer	0.000398	0.00364	CcSEcCtD
Haloperidol—Nausea—Lomustine—brain cancer	0.000398	0.00364	CcSEcCtD
Haloperidol—Hypotension—Procarbazine—brain cancer	0.000397	0.00364	CcSEcCtD
Haloperidol—H1F0—endocrine gland—brain cancer	0.000386	0.00308	CbGeAlD
Haloperidol—Insomnia—Procarbazine—brain cancer	0.000385	0.00352	CcSEcCtD
Haloperidol—Hepatobiliary disease—Temozolomide—brain cancer	0.000381	0.00349	CcSEcCtD
Haloperidol—H1F0—head—brain cancer	0.000381	0.00304	CbGeAlD
Haloperidol—DRD3—brain—brain cancer	0.000381	0.00304	CbGeAlD
Haloperidol—Somnolence—Procarbazine—brain cancer	0.000378	0.00346	CcSEcCtD
Haloperidol—DRD1—head—brain cancer	0.000376	0.003	CbGeAlD
Haloperidol—Anaemia—Hydroxyurea—brain cancer	0.000373	0.00341	CcSEcCtD
Haloperidol—Hallucination—Carmustine—brain cancer	0.000373	0.00341	CcSEcCtD
Haloperidol—Decreased appetite—Procarbazine—brain cancer	0.00037	0.00338	CcSEcCtD
Haloperidol—Connective tissue disorder—Carmustine—brain cancer	0.000368	0.00337	CcSEcCtD
Haloperidol—Constipation—Procarbazine—brain cancer	0.000364	0.00333	CcSEcCtD
Haloperidol—Hepatitis—Temozolomide—brain cancer	0.000362	0.00331	CcSEcCtD
Haloperidol—Dysphagia—Etoposide—brain cancer	0.000362	0.00331	CcSEcCtD
Haloperidol—Leukopenia—Hydroxyurea—brain cancer	0.000361	0.0033	CcSEcCtD
Haloperidol—Visual impairment—Carmustine—brain cancer	0.000361	0.0033	CcSEcCtD
Haloperidol—Hallucination—Temozolomide—brain cancer	0.00036	0.0033	CcSEcCtD
Haloperidol—SIGMAR1—pituitary gland—brain cancer	0.00036	0.00287	CbGeAlD
Haloperidol—Urinary tract disorder—Temozolomide—brain cancer	0.000357	0.00327	CcSEcCtD
Haloperidol—DRD2—telencephalon—brain cancer	0.000357	0.00285	CbGeAlD
Haloperidol—Bronchospasm—Etoposide—brain cancer	0.000356	0.00326	CcSEcCtD
Haloperidol—Connective tissue disorder—Temozolomide—brain cancer	0.000356	0.00325	CcSEcCtD
Haloperidol—Urethral disorder—Temozolomide—brain cancer	0.000355	0.00325	CcSEcCtD
Haloperidol—Sweating increased—Etoposide—brain cancer	0.000352	0.00323	CcSEcCtD
Haloperidol—KCNH2—telencephalon—brain cancer	0.000352	0.0028	CbGeAlD
Haloperidol—HTR1B—midbrain—brain cancer	0.000352	0.0028	CbGeAlD
Haloperidol—Feeling abnormal—Procarbazine—brain cancer	0.00035	0.00321	CcSEcCtD
Haloperidol—Eye disorder—Carmustine—brain cancer	0.00035	0.0032	CcSEcCtD
Haloperidol—Convulsion—Hydroxyurea—brain cancer	0.000349	0.0032	CcSEcCtD
Haloperidol—Visual impairment—Temozolomide—brain cancer	0.000349	0.00319	CcSEcCtD
Haloperidol—H1F0—central nervous system—brain cancer	0.000348	0.00277	CbGeAlD
Haloperidol—SIGMAR1—medulla oblongata—brain cancer	0.000347	0.00277	CbGeAlD
Haloperidol—DRD1—central nervous system—brain cancer	0.000344	0.00274	CbGeAlD
Haloperidol—Pancytopenia—Etoposide—brain cancer	0.000344	0.00314	CcSEcCtD
Haloperidol—HTR1B—spinal cord—brain cancer	0.000343	0.00273	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000341	0.00312	CcSEcCtD
Haloperidol—HTR1D—midbrain—brain cancer	0.00034	0.00271	CbGeAlD
Haloperidol—H1F0—cerebellum—brain cancer	0.00034	0.00271	CbGeAlD
Haloperidol—Neutropenia—Etoposide—brain cancer	0.000338	0.0031	CcSEcCtD
Haloperidol—Eye disorder—Temozolomide—brain cancer	0.000338	0.0031	CcSEcCtD
Haloperidol—Urticaria—Procarbazine—brain cancer	0.000338	0.00309	CcSEcCtD
Haloperidol—CBR1—brain—brain cancer	0.000337	0.00269	CbGeAlD
Haloperidol—Body temperature increased—Procarbazine—brain cancer	0.000336	0.00308	CcSEcCtD
Haloperidol—Cardiac disorder—Temozolomide—brain cancer	0.000336	0.00307	CcSEcCtD
Haloperidol—Alopecia—Carmustine—brain cancer	0.000331	0.00303	CcSEcCtD
Haloperidol—Oedema—Hydroxyurea—brain cancer	0.000329	0.00301	CcSEcCtD
Haloperidol—Angiopathy—Temozolomide—brain cancer	0.000328	0.003	CcSEcCtD
Haloperidol—Mental disorder—Carmustine—brain cancer	0.000328	0.003	CcSEcCtD
Haloperidol—Immune system disorder—Temozolomide—brain cancer	0.000327	0.00299	CcSEcCtD
Haloperidol—Mediastinal disorder—Temozolomide—brain cancer	0.000326	0.00298	CcSEcCtD
Haloperidol—Malnutrition—Carmustine—brain cancer	0.000326	0.00298	CcSEcCtD
Haloperidol—Nervous system disorder—Hydroxyurea—brain cancer	0.000323	0.00295	CcSEcCtD
Haloperidol—Thrombocytopenia—Hydroxyurea—brain cancer	0.000322	0.00295	CcSEcCtD
Haloperidol—Alopecia—Temozolomide—brain cancer	0.00032	0.00293	CcSEcCtD
Haloperidol—Skin disorder—Hydroxyurea—brain cancer	0.00032	0.00293	CcSEcCtD
Haloperidol—ABCB1—blood vessel—brain cancer	0.000318	0.00254	CbGeAlD
Haloperidol—SIGMAR1—midbrain—brain cancer	0.000317	0.00253	CbGeAlD
Haloperidol—Mental disorder—Temozolomide—brain cancer	0.000317	0.0029	CcSEcCtD
Haloperidol—Malnutrition—Temozolomide—brain cancer	0.000315	0.00288	CcSEcCtD
Haloperidol—Jaundice—Etoposide—brain cancer	0.000314	0.00288	CcSEcCtD
Haloperidol—Anorexia—Hydroxyurea—brain cancer	0.000314	0.00287	CcSEcCtD
Haloperidol—Hypersensitivity—Procarbazine—brain cancer	0.000313	0.00287	CcSEcCtD
Haloperidol—SIGMAR1—spinal cord—brain cancer	0.00031	0.00247	CbGeAlD
Haloperidol—HTR1B—endocrine gland—brain cancer	0.000309	0.00246	CbGeAlD
Haloperidol—Vision blurred—Carmustine—brain cancer	0.000307	0.00281	CcSEcCtD
Haloperidol—Tremor—Carmustine—brain cancer	0.000305	0.0028	CcSEcCtD
Haloperidol—Hepatobiliary disease—Etoposide—brain cancer	0.000305	0.00279	CcSEcCtD
Haloperidol—HTR1B—head—brain cancer	0.000305	0.00243	CbGeAlD
Haloperidol—Anaemia—Carmustine—brain cancer	0.000301	0.00276	CcSEcCtD
Haloperidol—Agranulocytosis—Etoposide—brain cancer	0.000301	0.00276	CcSEcCtD
Haloperidol—Pruritus—Procarbazine—brain cancer	0.000301	0.00275	CcSEcCtD
Haloperidol—Agitation—Carmustine—brain cancer	0.0003	0.00274	CcSEcCtD
Haloperidol—Vision blurred—Temozolomide—brain cancer	0.000297	0.00272	CcSEcCtD
Haloperidol—HTR1D—head—brain cancer	0.000295	0.00235	CbGeAlD
Haloperidol—Tremor—Temozolomide—brain cancer	0.000295	0.0027	CcSEcCtD
Haloperidol—Dyspnoea—Hydroxyurea—brain cancer	0.000293	0.00269	CcSEcCtD
Haloperidol—Somnolence—Hydroxyurea—brain cancer	0.000293	0.00268	CcSEcCtD
Haloperidol—Leukopenia—Carmustine—brain cancer	0.000292	0.00267	CcSEcCtD
Haloperidol—Anaemia—Temozolomide—brain cancer	0.000291	0.00266	CcSEcCtD
Haloperidol—Diarrhoea—Procarbazine—brain cancer	0.000291	0.00266	CcSEcCtD
Haloperidol—DRD2—pituitary gland—brain cancer	0.000291	0.00232	CbGeAlD
Haloperidol—Dyspepsia—Hydroxyurea—brain cancer	0.00029	0.00265	CcSEcCtD
Haloperidol—Agitation—Temozolomide—brain cancer	0.000289	0.00265	CcSEcCtD
Haloperidol—KCNH2—pituitary gland—brain cancer	0.000286	0.00228	CbGeAlD
Haloperidol—Decreased appetite—Hydroxyurea—brain cancer	0.000286	0.00262	CcSEcCtD
Haloperidol—Urinary tract disorder—Etoposide—brain cancer	0.000286	0.00262	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000284	0.0026	CcSEcCtD
Haloperidol—Urethral disorder—Etoposide—brain cancer	0.000284	0.0026	CcSEcCtD
Haloperidol—Vertigo—Temozolomide—brain cancer	0.000283	0.00259	CcSEcCtD
Haloperidol—Convulsion—Carmustine—brain cancer	0.000282	0.00258	CcSEcCtD
Haloperidol—HRH1—telencephalon—brain cancer	0.000282	0.00225	CbGeAlD
Haloperidol—Leukopenia—Temozolomide—brain cancer	0.000282	0.00258	CcSEcCtD
Haloperidol—Hypertension—Carmustine—brain cancer	0.000281	0.00258	CcSEcCtD
Haloperidol—Constipation—Hydroxyurea—brain cancer	0.000281	0.00258	CcSEcCtD
Haloperidol—Dizziness—Procarbazine—brain cancer	0.000281	0.00257	CcSEcCtD
Haloperidol—HTR1B—central nervous system—brain cancer	0.000278	0.00222	CbGeAlD
Haloperidol—Anxiety—Carmustine—brain cancer	0.000277	0.00253	CcSEcCtD
Haloperidol—KCNH2—medulla oblongata—brain cancer	0.000276	0.0022	CbGeAlD
Haloperidol—H1F0—brain—brain cancer	0.000276	0.0022	CbGeAlD
Haloperidol—HTR2B—head—brain cancer	0.000275	0.00219	CbGeAlD
Haloperidol—Convulsion—Temozolomide—brain cancer	0.000273	0.0025	CcSEcCtD
Haloperidol—DRD1—brain—brain cancer	0.000273	0.00217	CbGeAlD
Haloperidol—Hypertension—Temozolomide—brain cancer	0.000272	0.00249	CcSEcCtD
Haloperidol—Feeling abnormal—Hydroxyurea—brain cancer	0.000271	0.00248	CcSEcCtD
Haloperidol—Eye disorder—Etoposide—brain cancer	0.000271	0.00248	CcSEcCtD
Haloperidol—Vomiting—Procarbazine—brain cancer	0.00027	0.00247	CcSEcCtD
Haloperidol—HTR1D—central nervous system—brain cancer	0.000269	0.00215	CbGeAlD
Haloperidol—Cardiac disorder—Etoposide—brain cancer	0.000269	0.00246	CcSEcCtD
Haloperidol—Confusional state—Carmustine—brain cancer	0.000268	0.00246	CcSEcCtD
Haloperidol—Rash—Procarbazine—brain cancer	0.000268	0.00245	CcSEcCtD
Haloperidol—Dermatitis—Procarbazine—brain cancer	0.000268	0.00245	CcSEcCtD
Haloperidol—Anxiety—Temozolomide—brain cancer	0.000267	0.00245	CcSEcCtD
Haloperidol—Headache—Procarbazine—brain cancer	0.000266	0.00244	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000266	0.00244	CcSEcCtD
Haloperidol—Oedema—Carmustine—brain cancer	0.000266	0.00243	CcSEcCtD
Haloperidol—HTR2A—brainstem—brain cancer	0.000265	0.00211	CbGeAlD
Haloperidol—Angiopathy—Etoposide—brain cancer	0.000263	0.0024	CcSEcCtD
Haloperidol—Dry mouth—Temozolomide—brain cancer	0.000262	0.0024	CcSEcCtD
Haloperidol—Immune system disorder—Etoposide—brain cancer	0.000262	0.00239	CcSEcCtD
Haloperidol—Mediastinal disorder—Etoposide—brain cancer	0.000261	0.00239	CcSEcCtD
Haloperidol—Thrombocytopenia—Carmustine—brain cancer	0.00026	0.00238	CcSEcCtD
Haloperidol—Body temperature increased—Hydroxyurea—brain cancer	0.00026	0.00238	CcSEcCtD
Haloperidol—Tachycardia—Carmustine—brain cancer	0.00026	0.00238	CcSEcCtD
Haloperidol—Confusional state—Temozolomide—brain cancer	0.000259	0.00237	CcSEcCtD
Haloperidol—Oedema—Temozolomide—brain cancer	0.000257	0.00235	CcSEcCtD
Haloperidol—Anaphylactic shock—Temozolomide—brain cancer	0.000257	0.00235	CcSEcCtD
Haloperidol—DRD2—midbrain—brain cancer	0.000256	0.00204	CbGeAlD
Haloperidol—Alopecia—Etoposide—brain cancer	0.000256	0.00234	CcSEcCtD
Haloperidol—Anorexia—Carmustine—brain cancer	0.000254	0.00232	CcSEcCtD
Haloperidol—KCNH2—midbrain—brain cancer	0.000253	0.00201	CbGeAlD
Haloperidol—Nausea—Procarbazine—brain cancer	0.000253	0.00231	CcSEcCtD
Haloperidol—Nervous system disorder—Temozolomide—brain cancer	0.000252	0.00231	CcSEcCtD
Haloperidol—Thrombocytopenia—Temozolomide—brain cancer	0.000252	0.0023	CcSEcCtD
Haloperidol—HTR2B—central nervous system—brain cancer	0.000251	0.002	CbGeAlD
Haloperidol—Skin disorder—Temozolomide—brain cancer	0.00025	0.00229	CcSEcCtD
Haloperidol—Hypotension—Carmustine—brain cancer	0.000249	0.00228	CcSEcCtD
Haloperidol—Hyperhidrosis—Temozolomide—brain cancer	0.000249	0.00227	CcSEcCtD
Haloperidol—KCNH2—spinal cord—brain cancer	0.000247	0.00196	CbGeAlD
Haloperidol—SIGMAR1—cerebellum—brain cancer	0.000246	0.00196	CbGeAlD
Haloperidol—Anorexia—Temozolomide—brain cancer	0.000245	0.00224	CcSEcCtD
Haloperidol—Hypersensitivity—Hydroxyurea—brain cancer	0.000242	0.00222	CcSEcCtD
Haloperidol—Muscle spasms—Etoposide—brain cancer	0.000242	0.00222	CcSEcCtD
Haloperidol—CYP2D6—brainstem—brain cancer	0.000242	0.00193	CbGeAlD
Haloperidol—Insomnia—Carmustine—brain cancer	0.000241	0.0022	CcSEcCtD
Haloperidol—Dyspnoea—Carmustine—brain cancer	0.000237	0.00217	CcSEcCtD
Haloperidol—Somnolence—Carmustine—brain cancer	0.000236	0.00216	CcSEcCtD
Haloperidol—HTR2A—telencephalon—brain cancer	0.000236	0.00188	CbGeAlD
Haloperidol—Anaemia—Etoposide—brain cancer	0.000233	0.00213	CcSEcCtD
Haloperidol—CYP2C19—endocrine gland—brain cancer	0.000233	0.00185	CbGeAlD
Haloperidol—Insomnia—Temozolomide—brain cancer	0.000232	0.00213	CcSEcCtD
Haloperidol—Decreased appetite—Carmustine—brain cancer	0.000231	0.00212	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Carmustine—brain cancer	0.00023	0.0021	CcSEcCtD
Haloperidol—Dyspnoea—Temozolomide—brain cancer	0.000229	0.0021	CcSEcCtD
Haloperidol—Somnolence—Temozolomide—brain cancer	0.000229	0.00209	CcSEcCtD
Haloperidol—Constipation—Carmustine—brain cancer	0.000227	0.00208	CcSEcCtD
Haloperidol—Vertigo—Etoposide—brain cancer	0.000226	0.00207	CcSEcCtD
Haloperidol—Dyspepsia—Temozolomide—brain cancer	0.000226	0.00207	CcSEcCtD
Haloperidol—Leukopenia—Etoposide—brain cancer	0.000226	0.00207	CcSEcCtD
Haloperidol—DRD2—endocrine gland—brain cancer	0.000225	0.00179	CbGeAlD
Haloperidol—Diarrhoea—Hydroxyurea—brain cancer	0.000225	0.00206	CcSEcCtD
Haloperidol—Decreased appetite—Temozolomide—brain cancer	0.000223	0.00205	CcSEcCtD
Haloperidol—DRD2—head—brain cancer	0.000222	0.00177	CbGeAlD
Haloperidol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000222	0.00203	CcSEcCtD
Haloperidol—KCNH2—endocrine gland—brain cancer	0.000222	0.00177	CbGeAlD
Haloperidol—HTR1B—brain—brain cancer	0.000221	0.00176	CbGeAlD
Haloperidol—Constipation—Temozolomide—brain cancer	0.00022	0.00201	CcSEcCtD
Haloperidol—Feeling abnormal—Carmustine—brain cancer	0.000219	0.00201	CcSEcCtD
Haloperidol—KCNH2—head—brain cancer	0.000219	0.00175	CbGeAlD
Haloperidol—Convulsion—Etoposide—brain cancer	0.000218	0.002	CcSEcCtD
Haloperidol—Hypertension—Etoposide—brain cancer	0.000218	0.00199	CcSEcCtD
Haloperidol—Dizziness—Hydroxyurea—brain cancer	0.000218	0.00199	CcSEcCtD
Haloperidol—CYP2D6—telencephalon—brain cancer	0.000215	0.00171	CbGeAlD
Haloperidol—HTR1D—brain—brain cancer	0.000214	0.0017	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000213	0.00195	CcSEcCtD
Haloperidol—Feeling abnormal—Temozolomide—brain cancer	0.000212	0.00194	CcSEcCtD
Haloperidol—Body temperature increased—Carmustine—brain cancer	0.00021	0.00192	CcSEcCtD
Haloperidol—Vomiting—Hydroxyurea—brain cancer	0.000209	0.00192	CcSEcCtD
Haloperidol—Rash—Hydroxyurea—brain cancer	0.000207	0.0019	CcSEcCtD
Haloperidol—Confusional state—Etoposide—brain cancer	0.000207	0.0019	CcSEcCtD
Haloperidol—Dermatitis—Hydroxyurea—brain cancer	0.000207	0.0019	CcSEcCtD
Haloperidol—Headache—Hydroxyurea—brain cancer	0.000206	0.00189	CcSEcCtD
Haloperidol—Anaphylactic shock—Etoposide—brain cancer	0.000206	0.00188	CcSEcCtD
Haloperidol—Urticaria—Temozolomide—brain cancer	0.000204	0.00187	CcSEcCtD
Haloperidol—Body temperature increased—Temozolomide—brain cancer	0.000203	0.00186	CcSEcCtD
Haloperidol—DRD2—central nervous system—brain cancer	0.000203	0.00162	CbGeAlD
Haloperidol—Thrombocytopenia—Etoposide—brain cancer	0.000201	0.00184	CcSEcCtD
Haloperidol—Tachycardia—Etoposide—brain cancer	0.000201	0.00184	CcSEcCtD
Haloperidol—KCNH2—central nervous system—brain cancer	0.0002	0.00159	CbGeAlD
Haloperidol—Skin disorder—Etoposide—brain cancer	0.0002	0.00183	CcSEcCtD
Haloperidol—SIGMAR1—brain—brain cancer	0.000199	0.00159	CbGeAlD
Haloperidol—HTR2B—brain—brain cancer	0.000199	0.00159	CbGeAlD
Haloperidol—Hyperhidrosis—Etoposide—brain cancer	0.000199	0.00182	CcSEcCtD
Haloperidol—DRD2—cerebellum—brain cancer	0.000198	0.00158	CbGeAlD
Haloperidol—HTR2A—gonad—brain cancer	0.000197	0.00157	CbGeAlD
Haloperidol—Anorexia—Etoposide—brain cancer	0.000196	0.00179	CcSEcCtD
Haloperidol—Hypersensitivity—Carmustine—brain cancer	0.000196	0.00179	CcSEcCtD
Haloperidol—KCNH2—cerebellum—brain cancer	0.000195	0.00156	CbGeAlD
Haloperidol—Nausea—Hydroxyurea—brain cancer	0.000195	0.00179	CcSEcCtD
Haloperidol—Hypotension—Etoposide—brain cancer	0.000192	0.00176	CcSEcCtD
Haloperidol—HTR2A—pituitary gland—brain cancer	0.000192	0.00153	CbGeAlD
Haloperidol—CYP1A2—endocrine gland—brain cancer	0.00019	0.00151	CbGeAlD
Haloperidol—Hypersensitivity—Temozolomide—brain cancer	0.000189	0.00173	CcSEcCtD
Haloperidol—CYP1A1—endocrine gland—brain cancer	0.000187	0.00149	CbGeAlD
Haloperidol—HTR2A—medulla oblongata—brain cancer	0.000185	0.00147	CbGeAlD
Haloperidol—CYP1A1—head—brain cancer	0.000185	0.00147	CbGeAlD
Haloperidol—Dyspnoea—Etoposide—brain cancer	0.000183	0.00168	CcSEcCtD
Haloperidol—CYP3A5—endocrine gland—brain cancer	0.000183	0.00146	CbGeAlD
Haloperidol—Somnolence—Etoposide—brain cancer	0.000183	0.00167	CcSEcCtD
Haloperidol—Diarrhoea—Carmustine—brain cancer	0.000182	0.00167	CcSEcCtD
Haloperidol—Pruritus—Temozolomide—brain cancer	0.000182	0.00166	CcSEcCtD
Haloperidol—CYP2C9—endocrine gland—brain cancer	0.00018	0.00144	CbGeAlD
Haloperidol—Decreased appetite—Etoposide—brain cancer	0.000179	0.00164	CcSEcCtD
Haloperidol—HRH1—endocrine gland—brain cancer	0.000178	0.00142	CbGeAlD
Haloperidol—Gastrointestinal disorder—Etoposide—brain cancer	0.000178	0.00163	CcSEcCtD
Haloperidol—Dizziness—Carmustine—brain cancer	0.000176	0.00161	CcSEcCtD
Haloperidol—Constipation—Etoposide—brain cancer	0.000176	0.00161	CcSEcCtD
Haloperidol—Diarrhoea—Temozolomide—brain cancer	0.000176	0.00161	CcSEcCtD
Haloperidol—HRH1—head—brain cancer	0.000176	0.0014	CbGeAlD
Haloperidol—Dizziness—Temozolomide—brain cancer	0.00017	0.00156	CcSEcCtD
Haloperidol—Feeling abnormal—Etoposide—brain cancer	0.00017	0.00155	CcSEcCtD
Haloperidol—HTR2A—midbrain—brain cancer	0.000169	0.00135	CbGeAlD
Haloperidol—Vomiting—Carmustine—brain cancer	0.000169	0.00155	CcSEcCtD
Haloperidol—CYP1A1—central nervous system—brain cancer	0.000169	0.00135	CbGeAlD
Haloperidol—Rash—Carmustine—brain cancer	0.000168	0.00154	CcSEcCtD
Haloperidol—Dermatitis—Carmustine—brain cancer	0.000168	0.00153	CcSEcCtD
Haloperidol—Headache—Carmustine—brain cancer	0.000167	0.00153	CcSEcCtD
Haloperidol—HTR2A—spinal cord—brain cancer	0.000165	0.00131	CbGeAlD
Haloperidol—Vomiting—Temozolomide—brain cancer	0.000163	0.0015	CcSEcCtD
Haloperidol—Urticaria—Etoposide—brain cancer	0.000163	0.0015	CcSEcCtD
Haloperidol—Body temperature increased—Etoposide—brain cancer	0.000163	0.00149	CcSEcCtD
Haloperidol—Rash—Temozolomide—brain cancer	0.000162	0.00148	CcSEcCtD
Haloperidol—Dermatitis—Temozolomide—brain cancer	0.000162	0.00148	CcSEcCtD
Haloperidol—DRD2—brain—brain cancer	0.000161	0.00128	CbGeAlD
Haloperidol—Headache—Temozolomide—brain cancer	0.000161	0.00147	CcSEcCtD
Haloperidol—HRH1—central nervous system—brain cancer	0.00016	0.00128	CbGeAlD
Haloperidol—KCNH2—brain—brain cancer	0.000159	0.00127	CbGeAlD
Haloperidol—Nausea—Carmustine—brain cancer	0.000158	0.00145	CcSEcCtD
Haloperidol—ABCB1—telencephalon—brain cancer	0.000154	0.00123	CbGeAlD
Haloperidol—Nausea—Temozolomide—brain cancer	0.000153	0.0014	CcSEcCtD
Haloperidol—Hypersensitivity—Etoposide—brain cancer	0.000152	0.00139	CcSEcCtD
Haloperidol—HTR2A—endocrine gland—brain cancer	0.000149	0.00118	CbGeAlD
Haloperidol—HTR2A—head—brain cancer	0.000147	0.00117	CbGeAlD
Haloperidol—Pruritus—Etoposide—brain cancer	0.000146	0.00133	CcSEcCtD
Haloperidol—Diarrhoea—Etoposide—brain cancer	0.000141	0.00129	CcSEcCtD
Haloperidol—CYP3A4—endocrine gland—brain cancer	0.000138	0.0011	CbGeAlD
Haloperidol—Dizziness—Etoposide—brain cancer	0.000136	0.00125	CcSEcCtD
Haloperidol—CYP2D6—endocrine gland—brain cancer	0.000135	0.00108	CbGeAlD
Haloperidol—CYP1A1—brain—brain cancer	0.000134	0.00107	CbGeAlD
Haloperidol—HTR2A—central nervous system—brain cancer	0.000134	0.00107	CbGeAlD
Haloperidol—CYP2D6—head—brain cancer	0.000134	0.00106	CbGeAlD
Haloperidol—HTR2A—cerebellum—brain cancer	0.000131	0.00104	CbGeAlD
Haloperidol—Vomiting—Etoposide—brain cancer	0.000131	0.0012	CcSEcCtD
Haloperidol—Rash—Etoposide—brain cancer	0.00013	0.00119	CcSEcCtD
Haloperidol—Dermatitis—Etoposide—brain cancer	0.00013	0.00119	CcSEcCtD
Haloperidol—Headache—Etoposide—brain cancer	0.000129	0.00118	CcSEcCtD
Haloperidol—ABCB1—gonad—brain cancer	0.000129	0.00103	CbGeAlD
Haloperidol—HRH1—brain—brain cancer	0.000127	0.00101	CbGeAlD
Haloperidol—ABCB1—pituitary gland—brain cancer	0.000126	0.001	CbGeAlD
Haloperidol—CYP3A4—central nervous system—brain cancer	0.000124	0.000988	CbGeAlD
Haloperidol—Nausea—Etoposide—brain cancer	0.000122	0.00112	CcSEcCtD
Haloperidol—CYP2D6—central nervous system—brain cancer	0.000122	0.000972	CbGeAlD
Haloperidol—ABCB1—medulla oblongata—brain cancer	0.000121	0.000966	CbGeAlD
Haloperidol—CYP2D6—cerebellum—brain cancer	0.000119	0.00095	CbGeAlD
Haloperidol—ABCB1—midbrain—brain cancer	0.000111	0.000883	CbGeAlD
Haloperidol—ABCB1—spinal cord—brain cancer	0.000108	0.000862	CbGeAlD
Haloperidol—HTR2A—brain—brain cancer	0.000106	0.000847	CbGeAlD
Haloperidol—ABCB1—endocrine gland—brain cancer	9.73e-05	0.000776	CbGeAlD
Haloperidol—CYP2D6—brain—brain cancer	9.68e-05	0.000772	CbGeAlD
Haloperidol—ABCB1—head—brain cancer	9.61e-05	0.000766	CbGeAlD
Haloperidol—ABCB1—central nervous system—brain cancer	8.77e-05	0.000699	CbGeAlD
Haloperidol—ABCB1—cerebellum—brain cancer	8.57e-05	0.000683	CbGeAlD
Haloperidol—ABCB1—brain—brain cancer	6.96e-05	0.000555	CbGeAlD
Haloperidol—DRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.44e-05	0.00023	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—PIK3CG—brain cancer	1.42e-05	0.000227	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—BSG—brain cancer	1.42e-05	0.000227	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NOTCH2—brain cancer	1.42e-05	0.000227	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VAV1—brain cancer	1.4e-05	0.000224	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.39e-05	0.000222	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	1.38e-05	0.000222	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—BSG—brain cancer	1.38e-05	0.000221	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VAV1—brain cancer	1.37e-05	0.00022	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.35e-05	0.000216	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VAV1—brain cancer	1.35e-05	0.000216	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—PIK3CG—brain cancer	1.31e-05	0.000209	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—BSG—brain cancer	1.3e-05	0.000209	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP2C9—brain cancer	1.3e-05	0.000208	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—BSG—brain cancer	1.29e-05	0.000207	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—PIK3CG—brain cancer	1.29e-05	0.000206	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VAV1—brain cancer	1.29e-05	0.000206	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.28e-05	0.000204	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOTCH2—brain cancer	1.27e-05	0.000204	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SHH—brain cancer	1.27e-05	0.000203	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOTCH2—brain cancer	1.26e-05	0.000201	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SHH—brain cancer	1.25e-05	0.0002	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.25e-05	0.0002	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SHH—brain cancer	1.25e-05	0.0002	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ENO2—brain cancer	1.25e-05	0.000199	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TRPC6—brain cancer	1.22e-05	0.000196	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—IDH1—brain cancer	1.22e-05	0.000195	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VAV1—brain cancer	1.22e-05	0.000194	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000194	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HES1—brain cancer	1.2e-05	0.000193	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TRPC6—brain cancer	1.2e-05	0.000193	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SMO—brain cancer	1.2e-05	0.000193	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTCH1—brain cancer	1.2e-05	0.000193	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TRPC6—brain cancer	1.2e-05	0.000192	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VAV1—brain cancer	1.2e-05	0.000192	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—IDH1—brain cancer	1.19e-05	0.00019	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTCH1—brain cancer	1.18e-05	0.00019	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SMO—brain cancer	1.18e-05	0.00019	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTCH1—brain cancer	1.18e-05	0.000189	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SMO—brain cancer	1.18e-05	0.000189	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HES1—brain cancer	1.18e-05	0.000189	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ENO2—brain cancer	1.18e-05	0.000188	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—IL2—brain cancer	1.17e-05	0.000187	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HES1—brain cancer	1.16e-05	0.000186	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PDGFRA—brain cancer	1.15e-05	0.000184	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—IL2—brain cancer	1.14e-05	0.000183	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—IL2—brain cancer	1.12e-05	0.00018	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PDGFRA—brain cancer	1.12e-05	0.00018	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—IDH1—brain cancer	1.12e-05	0.000179	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SPP1—brain cancer	1.11e-05	0.000178	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—IDH1—brain cancer	1.11e-05	0.000178	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HES1—brain cancer	1.11e-05	0.000177	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PDGFRA—brain cancer	1.11e-05	0.000177	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—BSG—brain cancer	1.1e-05	0.000177	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SPP1—brain cancer	1.09e-05	0.000175	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.09e-05	0.000174	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.07e-05	0.000172	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SPP1—brain cancer	1.07e-05	0.000172	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.07e-05	0.000171	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.07e-05	0.000171	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL2—brain cancer	1.06e-05	0.00017	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.06e-05	0.000169	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.05e-05	0.000168	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HES1—brain cancer	1.05e-05	0.000167	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL2—brain cancer	1.04e-05	0.000166	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HES1—brain cancer	1.03e-05	0.000165	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SPP1—brain cancer	1.02e-05	0.000164	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL2—brain cancer	1.02e-05	0.000163	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—IL2—brain cancer	1.01e-05	0.000162	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IRS2—brain cancer	1.01e-05	0.000161	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2C9—brain cancer	1e-05	0.00016	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—IL2—brain cancer	9.99e-06	0.00016	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PDGFRA—brain cancer	9.95e-06	0.000159	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.92e-06	0.000159	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IRS2—brain cancer	9.86e-06	0.000158	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CG—brain cancer	9.86e-06	0.000158	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PDGFRA—brain cancer	9.82e-06	0.000157	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL2—brain cancer	9.75e-06	0.000156	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IRS2—brain cancer	9.7e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	9.7e-06	0.000155	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CG—brain cancer	9.68e-06	0.000155	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SPP1—brain cancer	9.66e-06	0.000155	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ENO2—brain cancer	9.63e-06	0.000154	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOTCH2—brain cancer	9.62e-06	0.000154	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SPP1—brain cancer	9.53e-06	0.000153	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—IDH1—brain cancer	9.49e-06	0.000152	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOTCH2—brain cancer	9.47e-06	0.000152	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOTCH2—brain cancer	9.45e-06	0.000151	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ENO2—brain cancer	9.4e-06	0.00015	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CG—brain cancer	9.4e-06	0.00015	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IRS2—brain cancer	9.26e-06	0.000148	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL2—brain cancer	9.19e-06	0.000147	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VAV1—brain cancer	9.17e-06	0.000147	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL2—brain cancer	9.07e-06	0.000145	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.05e-06	0.000145	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VAV1—brain cancer	9.03e-06	0.000144	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VAV1—brain cancer	9.01e-06	0.000144	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—APC—brain cancer	8.89e-06	0.000142	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CG—brain cancer	8.89e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ENO2—brain cancer	8.86e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ENO2—brain cancer	8.78e-06	0.000141	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IRS2—brain cancer	8.74e-06	0.00014	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—APC—brain cancer	8.71e-06	0.000139	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CG—brain cancer	8.71e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IRS2—brain cancer	8.62e-06	0.000138	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CG—brain cancer	8.57e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—APC—brain cancer	8.57e-06	0.000137	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—BSG—brain cancer	8.52e-06	0.000136	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—APC—brain cancer	8.18e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CG—brain cancer	8.18e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—EGFR—brain cancer	8.1e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—EGFR—brain cancer	7.93e-06	0.000127	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CG—brain cancer	7.91e-06	0.000127	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HES1—brain cancer	7.89e-06	0.000126	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—EGFR—brain cancer	7.81e-06	0.000125	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HES1—brain cancer	7.76e-06	0.000124	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HES1—brain cancer	7.75e-06	0.000124	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.73e-06	0.000124	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CG—brain cancer	7.72e-06	0.000123	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—APC—brain cancer	7.72e-06	0.000123	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—IL2—brain cancer	7.64e-06	0.000122	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CG—brain cancer	7.61e-06	0.000122	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—APC—brain cancer	7.61e-06	0.000122	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—IL2—brain cancer	7.52e-06	0.00012	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PDGFRA—brain cancer	7.51e-06	0.00012	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ENO2—brain cancer	7.5e-06	0.00012	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—IL2—brain cancer	7.5e-06	0.00012	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—EGFR—brain cancer	7.45e-06	0.000119	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PDGFRA—brain cancer	7.39e-06	0.000118	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.38e-06	0.000118	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—IDH1—brain cancer	7.33e-06	0.000117	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SPP1—brain cancer	7.29e-06	0.000117	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SPP1—brain cancer	7.18e-06	0.000115	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SPP1—brain cancer	7.16e-06	0.000115	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—EGFR—brain cancer	7.03e-06	0.000113	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RELA—brain cancer	6.95e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL2—brain cancer	6.94e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—EGFR—brain cancer	6.94e-06	0.000111	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—ERBB2—brain cancer	6.91e-06	0.000111	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL2—brain cancer	6.83e-06	0.000109	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL2—brain cancer	6.81e-06	0.000109	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RELA—brain cancer	6.8e-06	0.000109	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—ERBB2—brain cancer	6.76e-06	0.000108	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RELA—brain cancer	6.7e-06	0.000107	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—ERBB2—brain cancer	6.65e-06	0.000107	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IRS2—brain cancer	6.6e-06	0.000106	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IRS2—brain cancer	6.49e-06	0.000104	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IRS2—brain cancer	6.48e-06	0.000104	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RELA—brain cancer	6.39e-06	0.000102	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—ERBB2—brain cancer	6.35e-06	0.000102	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL2—brain cancer	6.26e-06	0.0001	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL2—brain cancer	6.13e-06	9.81e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCND1—brain cancer	6.1e-06	9.77e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CTNNB1—brain cancer	6.04e-06	9.67e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL2—brain cancer	6.03e-06	9.65e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RELA—brain cancer	6.03e-06	9.65e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ERBB2—brain cancer	5.99e-06	9.59e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCND1—brain cancer	5.97e-06	9.56e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RELA—brain cancer	5.95e-06	9.52e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CTNNB1—brain cancer	5.92e-06	9.47e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ERBB2—brain cancer	5.91e-06	9.46e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCND1—brain cancer	5.88e-06	9.41e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APC—brain cancer	5.82e-06	9.32e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CG—brain cancer	5.82e-06	9.32e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CTNNB1—brain cancer	5.82e-06	9.32e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO2—brain cancer	5.79e-06	9.27e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL2—brain cancer	5.76e-06	9.22e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CG—brain cancer	5.73e-06	9.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APC—brain cancer	5.73e-06	9.17e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.72e-06	9.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APC—brain cancer	5.72e-06	9.15e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CG—brain cancer	5.71e-06	9.15e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCND1—brain cancer	5.61e-06	8.98e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CTNNB1—brain cancer	5.56e-06	8.9e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL2—brain cancer	5.43e-06	8.69e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CG—brain cancer	5.4e-06	8.64e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL2—brain cancer	5.36e-06	8.57e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—brain cancer	5.32e-06	8.51e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—brain cancer	5.31e-06	8.5e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—brain cancer	5.29e-06	8.47e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—STAT3—brain cancer	5.27e-06	8.43e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CTNNB1—brain cancer	5.24e-06	8.39e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—brain cancer	5.22e-06	8.36e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—brain cancer	5.22e-06	8.36e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—brain cancer	5.21e-06	8.34e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—brain cancer	5.21e-06	8.34e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CTNNB1—brain cancer	5.17e-06	8.28e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—STAT3—brain cancer	5.16e-06	8.26e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—brain cancer	5.13e-06	8.2e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—STAT3—brain cancer	5.07e-06	8.12e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—brain cancer	4.89e-06	7.83e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—brain cancer	4.89e-06	7.83e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—STAT3—brain cancer	4.84e-06	7.75e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—brain cancer	4.79e-06	7.67e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—brain cancer	4.79e-06	7.66e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—brain cancer	4.72e-06	7.55e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—brain cancer	4.69e-06	7.5e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—brain cancer	4.61e-06	7.39e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—brain cancer	4.61e-06	7.38e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—brain cancer	4.57e-06	7.31e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—brain cancer	4.55e-06	7.29e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RELA—brain cancer	4.55e-06	7.29e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ERBB2—brain cancer	4.52e-06	7.24e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—brain cancer	4.51e-06	7.22e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—brain cancer	4.5e-06	7.21e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RELA—brain cancer	4.48e-06	7.17e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RELA—brain cancer	4.47e-06	7.15e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.45e-06	7.12e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ERBB2—brain cancer	4.44e-06	7.11e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CG—brain cancer	4.42e-06	7.07e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—brain cancer	4.4e-06	7.05e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CG—brain cancer	4.31e-06	6.9e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—brain cancer	4.25e-06	6.8e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—brain cancer	4.19e-06	6.7e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—brain cancer	4.15e-06	6.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL2—brain cancer	4.1e-06	6.56e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—brain cancer	4.1e-06	6.56e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CG—brain cancer	4.06e-06	6.5e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL2—brain cancer	4.03e-06	6.46e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CG—brain cancer	4.03e-06	6.45e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL2—brain cancer	4.02e-06	6.44e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—brain cancer	4.02e-06	6.43e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—brain cancer	4e-06	6.4e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.96e-06	6.33e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—brain cancer	3.94e-06	6.3e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—brain cancer	3.93e-06	6.29e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—brain cancer	3.92e-06	6.28e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.89e-06	6.23e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.89e-06	6.22e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—brain cancer	3.87e-06	6.2e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—brain cancer	3.7e-06	5.92e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—brain cancer	3.49e-06	5.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—brain cancer	3.48e-06	5.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—brain cancer	3.45e-06	5.52e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CG—brain cancer	3.44e-06	5.51e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—brain cancer	3.44e-06	5.51e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.43e-06	5.49e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—brain cancer	3.42e-06	5.48e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—brain cancer	3.39e-06	5.43e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—brain cancer	3.39e-06	5.42e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—brain cancer	3.21e-06	5.13e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—brain cancer	3.15e-06	5.05e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—brain cancer	3.15e-06	5.04e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—brain cancer	3.13e-06	5.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—brain cancer	3.08e-06	4.94e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—brain cancer	3.08e-06	4.93e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CG—brain cancer	2.66e-06	4.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—brain cancer	2.63e-06	4.21e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—brain cancer	2.59e-06	4.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—brain cancer	2.58e-06	4.14e-05	CbGpPWpGaD
